Effectively engage with patients to help improve adherence, drive better disease understanding, and deliver treatment value.
With wearables like Apple Watch making a transformative impact on healthcare, their potential for reimagining the patient experience is truly exciting. In a digital healthcare environment, support is integrated into the patient’s daily life and allows for real-time access; education is personalized with adaptive and reactive support for each individual; and ubiquitous, instantly available data leads to more intelligent and timely decision-making.
Wearable health monitors are accelerating the evolution of the patient experience and enabling new capabilities for pharma/biopharma developers. Where patient engagement and support has traditionally been high-touch (support and/or nursing provided at the patient’s home or via an in-clinic visit), today’s digital patient experience enables highly integrated virtual support. This new approach engages patients across a wider range of interactions and complements in-person interaction with remote support and consultations.
For patients, this digitally enhanced approach follows the shift away from generic patient education and one-size-fits-all content delivered via static, print-based materials. Instead, patients receive personalized education that offers tailored, reactive and adaptive support across multiple channels and delivers dynamic, actionable, interactive and rich digital content.
This shift is primarily enabled by better data: Under the traditional model, data was limited or siloed (if available at all) and was often stuck in multiple platforms stored in a mixture of structured and unstructured data. In contrast, today’s digital approach focuses on intelligent data aggregated from multiple sources and is instantly available.
The impacts of this evolution of the patient experience are significant, including:
Ultimately, IQVIA Patient Experience Solutions enable digital patient support programs (PSPs) to leverage an ecosystem familiar to the patient (and require minimal effort) to deliver digital interventions. This new patient experience helps improve operational program KPIs, as well as patient clinical outcomes and satisfaction measures.
Combining IQVIA’s market-leading data analytics with Apple’s best-in-class technology transforms patient experiences and better serves patient needs. IQVIA Connected Intelligence™ links traditional IQVIA data, advanced analytics, and healthcare expertise with the industry-leading capabilities and simplicity of the Apple HealthKit ecosystem to create a step-change in the patient experience.
This improvement starts with data collection, including:
Importantly, all this activity is at the patient’s discretion. Putting the patient in charge of what data is collected, how and with whom it is shared, and what level of interaction is acceptable are all features of Apple HealthKit. Apple is well known for keeping user data secure and protecting user privacy – capabilities that mirror IQVIA’s own commitment to patient privacy.
After the patient has opted in, IQVIA ingests, aggregates, stores and analyzes all available data to create actionable insights that are highly relevant across patient engagement and condition management, as shown in Figure 1.
Figure 1: Services across patient engagement & condition management
In particular, real-time passive data collection can enable hyper-personalized insights and influence dynamic support that changes and adapts based on those insights. For patients, benefits include:
Pharmaceutical companies and other health stakeholders also enjoy a range of benefits and new opportunities, including:
IQVIA Patient Experience Solutions create a paradigm shift that will impact well beyond a single solution or use case. It enables a range of possibilities, from digital patient support programs and prevention programs to real-world evidence generation programs (observational studies).
At this early stage, digital PSPs are one of the key drivers. PSPs are key to helping patients use their medications, and in recent years these programs have relied on virtual solutions (video calls, automated reminders, etc.) to meet that objective. But that is only the beginning — the future of PSPs is to leverage wearables to capture patient data and enable even more significant digital interventions.
While all this data and analysis lends itself to measuring real-time vital signs and identifying key outcomes in the moment, there is also long-term value in tracking the data over time. Building detailed histories is significantly easier, and more likely to succeed, with technologies like Apple HealthKit that passively gather patient data. Pharmaceutical companies with access to this granular level of real-world data will be able to uncover previously obscure connections and identify new avenues of inquiry. The possibilities are endless.
Learn more about https://www.iqvia.com/about-us/iqvia-patient-experience-solutions-with-apple-devices.
Effectively engage with patients to help improve adherence, drive better disease understanding, and deliver treatment value.